dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Dipeptidyl peptidase-4 Role of Dipeptidyl Peptidase 4
Description
doi: 10.3390/ijms20174092 [DOI] [PMC free article] [PubMed] [Google Scholar] 14.Nauck MA, Quast DR, Wefers J, Meier JJ
These findings indicate that GLP-1R activation specifically inhibits GSDMD-mediated microglial pyroptosis, a finding consistently replicated in subsequent in vitro experiments (Song et al., 2022)
Clinical trial in adolescents: A recent clinical trial showed that teens who were overweight or obese also lost weight on semaglutide
Mendonca, L., Moura, H., Chaves, P
Emerging Benefits for Other Conditions The therapeutic potential of GLP-1s continues to expand as research uncovers new applications
